Please follow Chris "Uranium" Oil: Nine Rogue Bloggers for Woodlarks update – last year we raised £26,000: in 2019, so far…
Sunday Long Reads: How to identify a body, Cargo Cults, Facebook Hell, Woodstock '99, Guantánamo’s Darkest Secret
Union Jack Oil – we not as pleased as it with sale of licence interest… but still imminent “company-changing” potential
Published 6 days ago
It is another piece in the jigsaw and it could turn out to be quite a large one. Optibiotix (OPTI) has announced that it has received a licence from the Food Standards and Safety Authority India (FSSAI) for its weight management product, SlimBiome to be manufactured in India. The approval was gained by Optibiotix's manufacturing partner, Zeon Life Sciences, for both SlimBiome and SlimBiome-containing products...
Published 58 days ago
These days Optibiotix (OPTI) is on the cusp of being or already profitable and as such what excites us are rapidly growing revenues and new sales and marketing agreements. We will not have to wait long at all for more news on both those fronts. But behind this great company is the IP, the science.
Published 103 days ago
OptiBiotix Health (OPTI) has announced that it has entered into an exclusive manufacturing and supply agreement with Zeon Lifesciences. The agreement grants Zeon an exclusive license to manufacture and supply OptiBiotix's SlimBiome weight management technology in India, in return for 50% of the profit...
Published 141 days ago
On Tuesday we learned how Optibiotix (OPTI) had secured medical device approval for Slimbiome and a CE Mark and that it had been working on this for two and a half years. We suggested that it would thus hit the ground running and so it was perfectly plausible that it could be delivering annualised profits of £7 million from this one product within two years. On Thursday we saw evidence of how well prepared it is for a rapid rollout.
Published 191 days ago
Having reached circa 130p in August, shares in OptiBiotix Health (OPTI) have slid to 78p-81p. This is despite a pipeline of seemingly very significant deals likely to be converted and as such…
Published 305 days ago
Maybe folks are getting immune about Optibiotix (OPTI) announcing yet another manufacturing and supply agreement. But even if, like this one, it is relatively small it all adds to the bottom line improvement. The latest one is with John Morley Foods, a 75 year old company operating in Cheshire with annual sales (2016) of £31 million, making six figure profits and with a growing cash pile.
Published 345 days ago
It is not exactly earth shattering but Optibiotix (OPTI) says that it will be showcasing "an extended range of products and presenting new research data on its LPLDL® and SlimBiome® products at the Vitafoods European tradeshow in Geneva from the 15-17 May 2018."
Published 355 days ago
OptiBiotix Health (OPTI) has added to recent newsflow aplenty with a distribution agreement for its SlimBiome weight management technology in the UK…
Published 528 days ago
There is no news of new distribution or partnership deals in this release but fear not they will come soon. Very soon. But none the less, the latest update from Optibiotix (OPTI) on progress at Slimbiome is very positive indeed and, yes, Tata, is mentioned.
Published 535 days ago
A big deal with a real name and a serious player which will lead to material profits for Optibiotix (OPTI). What more could we lucky shareholders want? These deals are racking up and will clearly leave the company reporting profits in 2019 and very big profits the year after. That is not discounted in the share price, currently 74p to buy.
Published 538 days ago
Okay we have been bullish on this one since the shares were 8p – when we bought our shares – but it has not raced ahead in recent months as much as we would have expected. The market simply has not appreciated the importance of recently announced deals and also the business model. Once it does, and that will come as other big deals are announced, the shares will move ahead very sharply indeed.
Published 560 days ago
This is non news and Optibiotix (OPTI) should fire whatever poltroons handle its PR for releasing it. Announcing guffe creates the impression that a company has nothing of substance to announce which is not the case.We, for instance, expect news of a massive Slimbiome Tata deal with hard numbers very soon.
Published 578 days ago
Ahead of a presentation in London, Optibiotix (OPTI) issued what you might term a "cleansing statement" allowing boss Steve O'Hara to talk freely. And the news is all good. Let's start with Slimbiome.
Published 591 days ago
Oh Ye of little faith!. There was big news on Tuesday for Optibiotix (OPTI). This was ONE of the big deals we were waiting for. There are more to follow but this should send critics of Optibiotix scuttling for cover as India's Tata is a giant. It has 660,000 employees and annual sales of $103.51 billion! Those who doubted us as we bought our first shares for two years HERE - at sub 55p a few weeks ago you can apologise. now. Go form an orderly queue. The shares are now 75p-77.5p and they are GOING MUCH HIGHER & SOON!
Published 704 days ago
OptiBiotix Health (OPTI) has announced what it terms the "successful" launch of its SlimBiome® and LPLDL® products at the Vitafoods Europe tradeshow in Geneva from the 9-11 of May 2017. The event provided the opportunity to connect with 16,500 industry decision makers from the supplements, nutraceutical, functional food and beverage industries. This is viewed as one of the world's leading trade fairs for the food and drinks industry. Yadda, yadda, yadda. Companies always say launches are successful. More jam tomorrow. So what. Etc. But no read on... We have underlined a few key words for you.
Published 725 days ago
The A-Grade A'holes at Walbrook PR who charge Optibiotix (OPTI) thousands of quid a month for "news management" probably thought putting out two announcements on one day was part of a clever strategy. Whatever. If Optibiotix wants to save a few quid we have a suggestion....
Published 812 days ago
Critics of Obtibiotix (OPTI) reckon that it is all jam tomorrow and it needs to announce big name deals which see real rollout of its products and commercialisation. Well how would a deal with Boots for its Slimbiome weight-loss drinks and snack bars do for starters?
Published 856 days ago
On 29 November Optibiotix (OPTI) stated: "OptiBiotix reports that it has reached late stage commercial discussions with six commercial partners across its technology and product platforms.". The knockers said "jam tomorrow won't happen". This week the first of the six deals was announced and it is massive. More will follow as Adam Reynolds made clear yesterday exclusively HERE. The news is:
Published 968 days ago
Results from the half calendar year from Optibiotix (OPTI) were very pleasing indeed but not orgasmic and that is why the shares are a tad weaker at 69p-72p. They are cheap but punters need to see more. They will not have to wait too long.